A British woman who was the first to undergo pioneering drug trials aimed at finding a cure for variant CJD, the human form of BSE, died on Friday after a lung infection caused a sudden decline in her health. In August, Rachel Forber, from Merseyside, in northwest England, became the first vCJD sufferer in the world to take the drug